Dr. Mulcahy on the Design of the EPOCH Trial in mCRC With Liver Metastases ByMary F. Mulcahy, MDJanuary 11th 2022Mary F. Mulcahy, MD, discusses the design of the phase 3 EPOCH trial in patients with metastatic colorectal cancer and liver metastases.
Dr. Mulcahy on Key Takeaways from the EPOCH Trial With TheraSphere Y-90 in CRCByMary F. Mulcahy, MDOctober 15th 2021Mary F. Mulcahy, MD, discusses the key takeaways from the ongoing EPOCH trial in patients with colorectal cancer and liver metastases.